Home › Funds › Lombard Odier Asset Management (Switzerland) SA › JNJ

Lombard Odier Asset Management (Switzerland) SA position in JNJ

JOHNSON & JOHNSON · Health Care

Lombard Odier Asset Management (Switzerland) SA reported holding 155,629 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$41.2M, representing 1.20% of its reported portfolio and ranking #13 among its reported holdings. Lombard Odier Asset Management (Switzerland) SA has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)155.63K sh
Reported value held$41.20M
Portfolio Weight1.20%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Lombard Odier Asset Management (Switzerland) SA's JNJ position evolved

Lombard Odier Asset Management (Switzerland) SA first disclosed a stake in JNJ in Q3 2023 at 17,825 shares (US$2.8M). The position peaked in Q3 2026 at 155,629 shares, worth US$41.2M. Across 13 filings, Lombard Odier Asset Management (Switzerland) SA increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 155,629 shares valued at US$41.2M — an increase of 16,200 shares quarter over quarter.. Notable position changes include a 30% increase in Q4 2023 (shares rose 1% over the following quarter), a 148% increase in Q1 2024 (shares fell 8% over the following quarter), a 75% increase in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.82K $2.78M New
Q4 2023 23.26K $3.65M Add
Q1 2024 57.60K $9.11M Add
Q2 2024 61.87K $9.04M Add
Q3 2024 66.61K $10.79M Add
Q4 2024 68.72K $9.94M Add
Q1 2025 120.42K $19.97M Add
Q2 2025 132.12K $20.18M Add
Q3 2025 128.73K $23.87M Reduce
Q4 2025 116.63K $24.14M Reduce
Q1 2026 135.23K $33.06M Add
Q2 2026 139.43K $35.41M Add
Q3 2026 155.63K $41.20M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$55.52B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Lombard Odier Asset Management (Switzerland) SA held JNJ?

Lombard Odier Asset Management (Switzerland) SA has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Lombard Odier Asset Management (Switzerland) SA's current position in JNJ?

As of Q3 2026, Lombard Odier Asset Management (Switzerland) SA holds 155.63K shares of JNJ (JOHNSON & JOHNSON), valued at $41.20M, representing 1.20% of its reported portfolio and ranking #13.

Has Lombard Odier Asset Management (Switzerland) SA been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Lombard Odier Asset Management (Switzerland) SA increased its position in JNJ. The position peaked in Q3 2026 at 155.63K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.